SGK1: a novel prognostic marker and potential drug target in medulloblastoma

被引：0
|
作者：
Pleier, S. [1 ,2 ]
Sturm, D. [1 ]
Remke, M. [1 ,2 ]
Witt, H. [1 ,2 ]
Goidts, V [1 ,2 ]
Reifenberger, G. [3 ]
Felsberg, J. [3 ]
Kulozik, A. E. [2 ]
Korshunov, A. [4 ]
Lichter, P. [1 ]
Pfister, S. M. [1 ,2 ]
机构：
[1] German Canc Res Ctr Heidelberg, Div Mol Genet, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[3] Univ Dusseldorf, Dept Neuropathol, D-4000 Dusseldorf, Germany
[4] Univ Heidelberg Hosp, Dept Neuropathol, Heidelberg, Germany
来源：
KLINISCHE PADIATRIE | 2011年 / 223卷 / 03期
关键词：
D O I：
10.1055/s-0031-1277081
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
20
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [21] The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma
    Li, Jiao
    Yu, Hui
    Wang, Xing
    Ye, Yingying
    Fang, Wei
    Ding, Ning
    Mi, Lan
    Ping, Lingyan
    Wang, Xiaogan
    Song, Yuqin
    Zhu, Jun
    CANCER CONTROL, 2022, 29
  • [22] Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer
    Al-Alem, Umaima
    Rauscher, Garth H.
    Alem, Qais Al
    Kajdacsy-Balla, Andre
    Mahmoud, Abeer M.
    CANCERS, 2023, 15 (12)
  • [23] A Novel SGK1 Inhibitor (SGK1-I), Prevents Obesity-Related Atrial Fibrillation
    Bapat, Aneesh
    Pradhananga, Sabindra
    Srinivasan, Dinesh
    Sager, Philip
    Ellinor, Patrick T.
    CIRCULATION, 2023, 148
  • [24] Discovery of Herbacetin as a Novel SGK1 Inhibitor to Alleviate Myocardial Hypertrophy
    Zhang, Shujing
    Wang, Yingchao
    Yu, Min
    Shang, Ye
    Chang, Yanxu
    Zhao, Hong
    Kang, Yu
    Zhao, Lu
    Xu, Lei
    Zhao, Xiaoping
    Difrancesco, Dario
    Baruscotti, Mirko
    Wang, Yi
    ADVANCED SCIENCE, 2022, 9 (02)
  • [25] Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma
    Remke, Marc
    Hering, Esther
    Gerber, Nicolas U.
    Kool, Marcel
    Sturm, Dominik
    Rickert, Christian H.
    Gerss, Joachim
    Schulz, Stefan
    Hielscher, Thomas
    Hasselblatt, Martin
    Jeibmann, Astrid
    Hans, Volkmar
    Ramaswamy, Vijay
    Taylor, Michael D.
    Pietsch, Torsten
    Rutkowski, Stefan
    Korshunov, Andrey
    Monoranu, Carmelia-Maria
    Fruehwald, Michael C.
    CHILDS NERVOUS SYSTEM, 2013, 29 (08) : 1253 - 1262
  • [26] Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma
    Marc Remke
    Esther Hering
    Nicolas U. Gerber
    Marcel Kool
    Dominik Sturm
    Christian H. Rickert
    Joachim Gerß
    Stefan Schulz
    Thomas Hielscher
    Martin Hasselblatt
    Astrid Jeibmann
    Volkmar Hans
    Vijay Ramaswamy
    Michael D. Taylor
    Torsten Pietsch
    Stefan Rutkowski
    Andrey Korshunov
    Carmelia-Maria Monoranu
    Michael C. Frühwald
    Child's Nervous System, 2013, 29 : 1253 - 1262
  • [27] Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents
    Maestro, Ines
    Madruga, Enrique
    Boya, Patricia
    Martinez, Ana
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [28] REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma
    Taylor, Pete
    Fangusaro, Jason
    Rajaram, Veena
    Goldman, Stewart
    Helenowski, Irene B.
    MacDonald, Tobey
    Hasselblatt, Martin
    Riedemann, Lars
    Laureano, Alvaro
    Cooper, Laurence
    Gopalakrishnan, Vidya
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (08) : 1713 - 1723
  • [29] Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma
    Lo, Ken C.
    Ma, Changxing
    Bundy, Brian N.
    Pomeroy, Scott L.
    Eberhart, Charles G.
    Cowell, John K.
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7022 - 7028
  • [30] SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease
    Lu, Run-qing
    Zhang, Yin-yin
    Zhao, Hai-qiu
    Guo, Rong-qun
    Jiang, Zhong-xing
    Guo, Rong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345